Comparison of rhesus and cynomolgus macaques in a Streptococcus pyogenes infection model for vaccine evaluation

Microbial Pathogenesis

Volumn 50, Issue 1, 2011, Pages 39-47

  Skinner, Julie M ^a   Caro Aguilar, Ivette C ^a   Payne, Angela M ^a   Indrawati, Lani ^a   Fontenot, Jane ^b   Heinrichs, Jon H ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF LOUISIANA AT LAFAYETTE   (United States)

Author keywords

Monkey infection; Streptococcus pyogenes

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYNOMOLGUS MONKEY; ENZYME LINKED IMMUNOSORBENT ASSAY; GROUP A STREPTOCOCCAL INFECTION; IMMUNOFLUORESCENCE TEST; MACACA; NONHUMAN; PHARYNGITIS; PRIORITY JOURNAL; RHESUS MONKEY; SPECIES COMPARISON; SPECIES DIFFERENCE; STREPTOCOCCUS PYOGENES; TONSILLITIS;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; DRUG RESISTANCE, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MACACA FASCICULARIS; MACACA MULATTA; MALE; MODELS, ANIMAL; PHAGOCYTOSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

ANIMALIA; BACTERIA (MICROORGANISMS); MACACA; MACACA MULATTA; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 78650593942     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2010.10.004     Document Type: Article

References (37)

1. Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005, 5(11):685-694.
2. Murphy G.E. Attempts to induce rheumatic fever in experimental animals. A symposium on rheumatic fever 1952, 150-169. University of Minnesota Press, Minneapolis. L. Thomas (Ed.).
3. Popova I.P. Med Pribvl k Morsk Sborn Nov. 1887, 401-402.
4. Husmann L.K., Dillehay D.L., Jennings V.M., Scott J.R. Streptococcus pyogenes infection in mice. Microb Pathog 1996, 20(4):213-224.
5. Lymbury R.S., Olive C., Powell K.A., Good M.F., Hirst R.G., LaBrooy J.T., et al. Induction of autoimmune valvulitis in Lewis rats following immunization with peptides from the conserved region of group A streptococcal M protein. J Autoimmun 2003, 20(3):211-217.
6. Neely M.N., Pfeifer J.D., Caparon M. Streptococcus-zebrafish model of bacterial pathogenesis. Infect Immun 2002, 70(7):3904-3914.
7. Piepmeier E., Hammett-Stabler C., Price M., Peters J., Kemper G., Davis M. Myositis and fasciitis associated with group A beta hemolytic streptococcal infections: development of a rabbit model. J Lab Clin Med 1995, 126(2):137-143.
8. Roberts S., Scott J.R., Husmann L.K., Zurawski C.A. Murine models of Streptococcus pyogenes infection. Curr Protoc Microbiol 2006, Chapter 9:Unit 9D 5.
9. Saetre T., Hoiby E.A., Aspelin T., Lermark G., Lyberg T. Acute serogroup A streptococcal shock: a porcine model. J Infect Dis 2000, 182(1):133-141.
10. Sumby P., Tart A.H., Musser J.M. A non-human primate model of acute Group A Streptococcus pharyngitis. Methods mol biol 2006, 255-267. Humana Press, Totowa, NJ. F. Otto, M. Da (Eds.).
11. Virtaneva K., Graham M.R., Porcella S.F., Hoe N.P., Su H., Graviss E.A., et al. Group A Streptococcus gene expression in humans and cynomolgus macaques with acute pharyngitis. Infect Immun 2003, 71(4):2199-2207.
12. Ashbaugh C.D., Moser T.J., Shearer M.H., White G.L., Kennedy R.C., Wessels M.R. Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol 2000, 2(4):283-292.
13. Gryllos I., Cywes C., Shearer M.H., Cary M., Kennedy R.C., Wessels M.R. Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol Microbiol 2001, 42(1):61-74.
14. Gryllos I., Grifantini R., Colaprico A., Cary M.E., Hakansson A., Carey D.W., et al. PerR confers phagocytic killing resistance and allows pharyngeal colonization by group A Streptococcus. PLoS Pathog 2008, 4(9):e1000145.
15. Kohler W., Djikidse E.K., Kuhnemund O., Knoll H., Magakjan G.O., Jurgens I. The immunobiology of M-proteins of Streptococcus pyogenes. III. Immunization of rhesus monkeys (Macaca mulatta). Allergie Immunologie 1976, 22(2):197-225.
16. Krause R.M., Rammelkamp C.H. Studies of the carrier state following infection with group A streptococci. II. Infectivity of streptococci isolated during acute pharyngitis and during the carrier state. J Clin Invest 1962, 41:575-578.
17. Shea P.R., Virtaneva K., Kupko J.J., Porcella S.F., Barry W.T., Wright F.A., et al. Interactome analysis of longitudinal pharyngeal infection of cynomolgus macaques by group A Streptococcus. Proc Natl Acad Sci USA 2010, 107(10):4693-4698.
18. Sumby P., Barbian K.D., Gardner D.J., Whitney A.R., Welty D.M., Long R.D., et al. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci USA 2005, 102(5):1679-1684.
19. Virtaneva K., Porcella S.F., Graham M.R., Ireland R.M., Johnson C.A., Ricklefs S.M., et al. Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc Natl Acad Sci USA 2005, 102(25):9014-9019.
20. Watson R.F., Rothbard S., Swift H.F. Type-specific protection and immunity following intranasal inoculation of monkeys with Group a hemolytic Streptococci. J Exp Med 1946, 84(2):127-142.
21. Feinstein A.R., Levitt M. The role of tonsils in predisposing to streptococcal infections and recurrences of rheumatic fever. N Engl J Med 1970, 282(6):285-291.
22. Kaplan E.L., Ferrieri P., Wannamaker L.W. Comparison of the antibody response to streptococcal cellular and extracellular antigens in acute pharyngitis. J Pediatr 1974, 84(1):21-28.
23. Bessen D., Fischetti V.A. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun 1988, 56(10):2666-2672.
24. Lancefield R.C. Current knowledge of type-specific M antigens of group A streptococci. J Immunol 1962, 89:307-313.
25. Seegal B., Heller G., Jablonowitz J. Incidence of hemolytic Streptococci and Pneumococci in the Pharyngeal Flora of normal rhesus monkeys. Proc Soc Exp Biol Med 1936, 34:812-816.
26. Friou G.J. Experimental infection of the upper respiratory tract of young chimpanzees with group A hemolytic streptococci. J Infect Dis 1950, 86(3):264-274.
27. Taranta A., Spagnuolo M., Davidson M., Goldstein G., Uhr J.W. Experimental streptococcal infections in baboons. Transplant Proc 1969, 1(4):992-993.
28. Choby B.A. Diagnosis and treatment of streptococcal pharyngitis. Am Fam Physician 2009, 79(5):383-390.
29. Zimmerman R.A., Krushak D.H., Wilson E., Douglas J.D. Human streptococcal disease syndrome compared with observations in chimpanzees. II. Immunologic responses to induced pharyngitis and the effect of treatment. J Infect Dis 1970, 122(4):280-289.
30. Sitkiewicz I., Nagiec M.J., Sumby P., Butler S.D., Cywes-Bentley C., Musser J.M. Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2. Proc Natl Acad Sci USA 2006, 103(43):16009-16014.
31. Lancefield R.C. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med 1959, 110(2):271-292.
32. Olive C., Clair T., Yarwood P., Good M.F. Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope. Vaccine 2002, 20(21-22):2816-2825.
33. Beres S.B., Sylva G.L., Barbian K.D., Lei B., Hoff J.S., Mammarella N.D., et al. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci USA 2002, 99(15):10078-10083.
34. Reichardt W., Gubbe K., Schmidt K.H. M3-protein with close sequence homology to M12 protein binds fibrinogen, albumin, fibronectin, but not to any subclass of IgG-localization of binding regions. Dev Biol Stand 1995, 85:179-182.
35. Hayman W.A., Brandt E.R., Relf W.A., Cooper J., Saul A., Good M.F. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Int Immunol 1997, 9(11):1723-1733.
36. Lancefield R.C. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med 1957, 106(4):525-544.
37. Olive C., Ho M.F., Dyer J., Lincoln D., Barozzi N., Toth I., et al. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis 2006, 193(12):1666-1676.